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Abstract 
Background: A significant relationship exists between the volume of surgical procedures that a given center 
performs and subsequent outcomes. It seems plausible that such a volume–outcome relationship is also present in 
dialysis.
Methods: MEDLINE and EMBASE were searched in November 2014 for non-experimental studies evaluating the 
association between center volume and patient outcomes [mortality, morbidity, peritonitis, switch to hemodialysis 
(HD) or any other treatment], without language restrictions or other limits. Selection of relevant studies, data extrac-
tion and critical appraisal were performed by two independent reviewers. We did not perform meta-analysis due to 
clinical and methodological heterogeneity (e.g. different volume categories).
Results: 16 studies met out inclusion criteria. Most studies were performed in the US. The study quality ranged from 
fair to good. Only few items were judged to have a high risk of bias, while many items were judged to have an unclear 
risk of bias due to insufficient reporting. All 10 studies that analyzed peritoneal dialysis (PD) technique survival by 
modeling switch to HD or any other treatment as an outcome showed a statistical significant effect. The relative effect 
measures ranged from 0.25 to 0.94 (median 0.73) in favor of high volume centers. All nine studies indicated a lower 
mortality for PD in high volume centers, but only study was statistical significant.
Conclusions: This systematic review supports a volume–outcome relationship in peritoneal dialysis with respect to 
switch to HD or any other treatment. An effect on mortality is probably present in HD. Further research is needed to 
identify and understand the associations of center volume that are causally related to patient benefit.
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Background
Previous systematic reviews (SR) have shown the pres-
ence of a significant relationship between the volume 
of surgical procedures that a given center performs and 
subsequent outcomes [1–6]. This so-called volume–out-
come relationship is reported to be stronger in high risk, 
low volume procedures [7–10]. The volume–outcome 
relationship has also been found outside of surgery [11, 
12]. Two hypotheses exist for this relationship. On the 
one hand, a higher caseload and experience may result 
in more effective skills (“practice makes perfect”). On 
the other, providers with better outcomes might receive 
more referrals thereby increasing their volume (“selective 
referral”) [13, 14].
Outcomes in dialysis are very heterogeneous in inter-
national research [15–17]. Such differences even remain 
after adjusting for measured patient characteristics [18]. 
Acknowledging residual confounding as an ever-present 
issue, center-related attributes are likely to be the main 
contributing factor. It is plausible that volume–outcome 
relationships are causal or intermediate variables on the 
pathway between center effect and patient outcomes (e.g. 
mortality risk).
To the best of our knowledge, there is no reported SR 
on the volume–outcome relationship in dialysis. We 
also did not find any ongoing SR by checking registries 
(Cochrane library and PROSPERO). The aim of this SR 
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is to examine the effects of center volume, specialization 
and regionalization on the outcomes in dialysis.
Methods
We performed a systematic literature search to identify 
all relevant publications on the relationship between 
center volume and patient outcomes in dialysis. Medline 
(via PubMed) and Embase (via Embase) were searched 
from inception to November 2014 (see Additional file 1: 
Appendix S1 for search strategies). Reference lists of 
retrieved articles were inspected to identify additional 
articles that could have been missed by our search strat-
egy. No language restrictions or other limits were applied.
For consideration in this SR the following inclusion 
criteria were applied to each publication: the subject of 
the study was dialysis [either peritoneal dialysis (PD) or 
hemodialysis (HD)]; the study had a comparative design; 
patient outcomes (e.g. mortality, morbidity, peritoni-
tis, switch to HD) were studied; volume was defined as 
a distinct number (e.g. continuous variable) or a cut-off 
value, or specialized/regionalized centers were analysed; 
the study did not describe a single center. All titles and 
abstracts were screened independently by two persons 
and the full texts of potentially eligible articles were 
then obtained and further assessed for eligibility against 
the review inclusion criteria. Any disagreements were 
resolved by discussion.
Data were extracted by one reviewer into structured 
summary tables and checked for accuracy by a second 
reviewer. Any disagreements were discussed until till con-
sensus was reached. For each publication, we extracted 
data on patient characteristics; setting; data source(s); 
center volume definition; and results. In accordance with 
prior SRs investigating the volume–outcome relationship 
we extracted only the comparison for the highest volume 
category vs. the lowest volume category, as defined by 
the study authors. If necessary, effect measures such as 
odds ratios (OR), risk ratios (RR) or hazard ratios (HR) 
were recalculated in order to achieve that the results are 
always presented as comparing high volume centers with 
low volume centers (and not vice versa). Furthermore, 
we also calculated relevant effect measures if these were 
not reported by the study authors, but were available 
from the text. In case of unadjusted and adjusted analy-
sis presented in the studies, we focused on the adjusted 
results. At all stages of data selection, data extraction and 
critical appraisal we contacted authors for clarification, if 
needed.
Methodological quality of the eligible studies was 
undertaken independently by two persons. Any disagree-
ments were resolved by discussion. We utilized a quality 
assessment tool based on the Newcastle–Ottawa-Scale 
[19] that was recently used in a Cochrane review that 
investigated the volume–outcome relationship in colo-
rectal cancer [20]. We made some minor adaptations 
when applying the tool to registry-based studies, around 
the last two questions dealing with incomplete data and 
missing data. It is quite likely that many registries might 
only incorporate data of cases with complete data. Under 
these circumstances a question on incomplete or missing 
data would be inappropriate as an assessment of quality. 
We made a considered judgement to replace these two 
questions for all registry-based studies, and evaluated the 
“quality of registry data” and the “selection of patients” 
instead. Both questions were previously used for a similar 
question related to the volume–outcome relationship in 
registry-based studies [12]. For all other studies, we used 
the original assessment tool from the Cochrane review by 
Archampong et  al. [20], but omitted the first item con-
cerning study design. For this particular clinical ques-
tion, we deemed it inappropriate to include retrospective 
study design per se as a criterion for determining degree 
of bias. In the SR by Archampong et al., all registry-based 
studies were assessed to have a high risk of bias as a result 
of their retrospective design, despite the fact that many 
collect information prospectively. We obtained literature 
for additional information about the corresponding reg-
istries, if referenced by the study authors. Our modified 
assessment tool can be found in Additional file 2: Appen-
dix S2, which has already been used successfully in a SR 
investigating the volume–outcome relationship in the 
Norwood procedure [21].
Because the identified studies were expected to be 
methodologically diverse (for example, different volume 
definitions), we decided a priori not to statistically com-
bine results.
A p-level of  <0.05 was considered statistically 
significant.
Results
The search strategy generated 251 hits, of which 16 
studies [22–37] met our inclusion criteria (Fig. 1). A list 
of excluded studies can be found in Additional file  3: 
Appendix S3. All 16 studies dealt with volume, while 
one study also contained data on hospital type [23]. In 
total, there were 15 registry-based studies and one clini-
cal study [36]. Six studies were from the US [24, 25, 27, 
34–36], four from France [26, 28, 31, 32], three from 
Canada [23, 29, 30], and each one study from Brazil [33], 
the Netherlands [22], and Romania [37]. All French stud-
ies were based on data from the French Peritoneal Dialy-
sis Registry (RDPLF) and all Canadian studies were based 
on the Canadian Organ Replacement Register (CORR). 
The observation periods varied across all studies with the 
longest follow-up being 16 years in one study [23]. Simi-
larly, the volume definitions varied extensively and were 
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often not well reported. The number of volume catego-
ries ranged from two [22, 24, 25, 30, 36, 37] to seven [28].
Study quality
Table  1 summarizes the results of the quality assess-
ment. The study quality ranged from fair to good. There 
were only few items that were judged to have a high risk 
of bias. However, many items were judged to have an 
unclear risk of bias. This was mainly the result of insuf-
ficient reporting. In this context, many problems arose in 
particular when rating the outcome variables. However, 
it should be noted that an unclear risk of bias should be 
interpreted taking the character of the outcome variable 
under study into account. This explains the diverging 
outcome assessments for mortality and peritonitis, for 
example. Death as an outcome variable is more reliable 
than peritonitis. There was each one single best study for 
PD [28] and HD [27].
Center volume
PD
Ten studies analyzed PD technique survival by mode-
ling switch to HD or any other treatment as an outcome 
[22–26, 28, 31, 32, 34, 36]. All studies showed a statisti-
cally significant result in favor of high volume facilities 
(Table 2). The relative effect measures ranged from 0.25 
to 0.94 (median 0.73). However, it should be noted that 
four studies [26, 28, 31, 32] were based on the RDPLF 
and two [24, 34] studies were based on data from the 
Baxter Healthcare Corporation. Taking the observation 
periods into account, an overlap of participants will have 
occurred for both databases, although the overlap is 
likely to be greater for the RDPLF.
Nine studies analyzed patient survival by modeling 
mortality risk as an outcome [22, 23, 25, 26, 28, 31, 32, 34, 
36]. Although the majority of studies indicated a slightly 
lower mortality or even a null effect for high volume 
facilities, only one study was able to prove this effect sta-
tistically yielding a RR =  0.71 (95 % CI 0.63–0.81) [23]. 
This analysis had an observation period from 1981 to 
1997. Limiting the observation period from 1990 to 1997 
resulted in a stronger effect with a RR =  0.51 (95  % CI 
0.41–0.64).
Among four studies investigating peritonitis as an out-
come [26, 31, 33, 35], one study based on data from the 
Brazilian Peritoneal Dialysis Study revealed lower rates of 
peritonitis in high volume centers yielding a HR =  0.67 
(95 % CI 0.46–0.98) [33]. The other studies did not reach 
statistical significance.
HD
One large study found patients on HD treated in high 
volume facilities to survive longer [27]. The unadjusted 
OR for 1 year survival was 1.24 (95 % CI 1.21–1.28) when 
high volume facilities were compared to low volume 
facilities. The OR increased to 1.29 (95 % CI 1.26–1.32) 
for 4 year survival. Adjusted analyses were performed for 
patients with and without diabetes as their primary cause 
of end stage renal disease (ESRD). Statistical significant 
HRs were found in both groups per 10 unit increase.
Potentially relevant articles identified 
and screened for retrieval
n = 299
Articles retrieved for more detailed 
evaluation 
n = 33
Excluded as abstract or 
title unsuitable 
n = 273
Studies included in SR
n = 16
Studies excluded n = 17
No dialysis n = 2
No center volume/characteristic n = 10
No patient outcomes n = 5
Identified from reference check
n = 7
Fig. 1 Flow chart
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PD and HD
Two studies analysed data from the CORR. One 
study found a statistically significant lower mortality 
(RR = 0.85; 95 % CI 0.78–0.91) in high volume hospitals 
[30]. The second study included only patients older than 
64  years and resulted in a very similar effect yielding a 
RR = 0.84 (p = 0.07) but failed to reach statistical signifi-
cance [29]. A third study for Romania found an adjusted 
HR of 0.88 (95 % CI 0.81–0.97) [37].
Discussion
This article reviewed the existing literature on the vol-
ume–outcome relationship in dialysis. PD was studied 
most intensively. Therein, the majority of studies investi-
gated either patient survival or technique survival as out-
comes. With respect to PD, center volume has an effect 
on technique survival only. There was no effect on mor-
tality risk or patient survival, while the evidence for peri-
tonitis is inconclusive due to a limited number of studies. 
There is also not much evidence for HD, where only one 
study was available. Not withstanding, that study did 
show a strong effect of center volume on mortality. Stud-
ies analysing PD and HD together seem to support this 
finding. It can be concluded, that regarding mortality, 
there is no associated volume–outcome relationship in 
PD, but possibly in HD. No patient outcomes other than 
mortality have been studied for HD and HD/PD. Center 
type has only been investigated in one study, making it 
impossible to draw definitive conclusions.
Limitations of the included studies
A number of methological issues impede consistent 
interpretation of the included studies. All studies are 
non-experimental raising questions in particular with 
respect to quality and completeness of data. Center vol-
ume as an explanatory variable can be confusing as the 
number of treated patients may classify the same center 
as either low volume or high volume, depending on geo-
political context. Center volume was defined in a num-
ber of different ways for all of our included studies. This 
is contrasts with surgical literature, where definitions of 
volume are more consistent yielding comparable results 
and providing convergent validity [38].
The time-varying nature of center volume as it pertains 
to dialysis is also problematic. For surgical procedures, 
patients undergo an operation and perhaps an inpatient 
stay depending on their requirements for recovery. Vol-
ume is modelled by annual caseloads, taking center vol-
ume either in the same year of patient’s admission [39] 
or 1 year before [40]. The temporal relationship between 
volume and outcome is therefore close. In contrast, ESRD 
is a chronic disease requiring indefinite treatment, with 
outcomes measured and reported over prolonged peri-
ods. Given the organic growth in ESRD, patient volumes 
Table 1 Study quality





















Afolalu 2009 [25] – + – + ? NA ? –
Castrale 2010 [26] – ? + + ? ? + +
Eisenstein 2008 [27] + + + + NA NA – +
Evans 2013 [28] + + + + + NA + +
Fenton 1997 [29] + + + + NA NA ? ?
Fenton 1993 [30] – ? ? + NA NA ? –
Guo
2003 [24]
+ ? + NA ? NA ? –
Huisman 2002 [22] + ? ? + ? NA + +
Lobbedez 2011 [31] – + + NA ? ? + ?
Lobbedez 2013 [32] + + + + ? NA + –
Martin 2011 [33] + + + NA NA ? ? +
Mircescu 2014 [37] + ? + + NA NA ? ?
Mujais 2006 [34] ? ? ? NA ? NA ? ?
Nolph 1986 [35] – ? ? NA NA ? + ?
Plantinga 2009 [36] + + ? + ? NA ? ?
Schaubel 2001 [23] + ? + + ? NA ? ?
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are likely to vary and most likely increase over time in a 
given centre. If studies are performed over a prolonged 
period of observation, associations may be potentially 
biased by the use of baseline values for centre volume, 
or weakened if the authors take the mean over the whole 
study period.
In general, the authors of the included studies failed to 
justify their rationale for definition and categorization 
of centre volume. We cannot presume that their model-
ling choices were data driven, and many appear arbitrary. 
Interestingly, we found all studies analyzing volume as a 
categorical variable. There are advantages and disadvan-
tages to this approach. Categorization of continuous data 
does avoid the presumption of any mathematical rela-
tionship, but can obscure associations and prevent deep 
understanding of data [41–43]. Prior research has shown 
that the volume–outcome relationship in surgery can be 
linear, stepwise, curvelinear or U-shaped, for example 
[44–47], and this requires further elucidation for dialysis.
As the included studies were observational, appropri-
ate adjustment for possible confounders is critical. This 
is particularly relevant for studies investigating the vol-
ume–outcome relationship [48, 49]. All of the included 
studies made adjustments as possible, but were limited 
by data availability. A large but unquantifiable degree 
of residual confounding is therefore likely from omitted 
known patient-level and centre-level risk factors [15–18, 
50–55].
Limitations of the review
We acknowledge that our work has some limitations. 
First, we did not search for grey literature. This might 
have yielded additional information. However, we have 
cross-checked the references of all included studies and 
were able to include three studies that were not retrieved 
by our search strategy. Publication bias is difficult to 
assess. It should be noted that there are many dialysis 
registries available worldwide. Thus it is likely that more 
evidence could be produced within a short time from 
ongoing analysing at these registries.
Our systematic review did not aim to provide cut-off 
values. Cut-off values could be extended to minimum 
volume standards. Such standards already exist in sur-
gery, but are well justified by robust volume–outcome 
data [56–60]. In dialysis, there are not only philosophi-
cal challenges as discussed, but also methodological 
issues to defining cut-off volumes that have not yet been 
explored in this area [61]. The contextual limitations of 
the included studies precluded us from defining or even 
suggesting cut-off values.
A point to note is that we did not use a validated tool 
to appraise study quality, but instead developed our own 
tool based on one from a previous Cochrane review. The 
rationale for this is that there is no tool that can be con-
sidered the ‘gold standard’ for this kind of clinical ques-
tion/study designs. However, the quality assessment of 
a registry-based study remains challenging, resulting in 
numerous studies where the items could not be assessed 
as the publications provided no information on it. We 
have already faced this problem in an earlier SR [21]. 
Although there is much literature related to the quality of 
registries [62, 63], there is no accepted critical appraisal 
tool for registry-based studies or for registry-based stud-
ies specific items. The idea of a registry of registries has 
already been suggested [64], and this might be helpful 
for future SRs based on registry-based studies. Report-
ing standards for registry-based studies would further 
encourage authors to report relevant information to facil-
itate the assessment of the methodological quality.
This systematic review focused only on center volume 
or center type effects. As for many surgical procedures 
and other medical conditions, it is also possible to focus 
on the physician volume. One recent study found that 
nephrologists with the lowest patient mortality rates had 
significantly lower patient caseloads than nephrologists 
with the highest mortality rates [65].
Conclusion
In conclusion, this systematic review supports a volume–
outcome relationship in PD with respect to switch to HD 
or any other treatment. An effect on mortality is probably 
present in HD. Center volume itself can only be regarded 
as a proxy for quality of care, and further research is 
needed to identify the associations of center volume that 
are causally related to patient benefit. There is a surpris-
ing dearth of literature in the area, and such data would 
be valuable for quality initiatives in order to help identi-
fied low performing centers achieve better outcomes for 
their patients.
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